Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Cancer Biology & Therapy
|
January 17, 2004
Suppression of epithelial cell transformation and induction of actin dependent differentiation by dominant negative Rac1, but not Ras, Rho or Cdc42
Margaret P Quinlan
Journal of Cellular Physiology
|
June 3, 2004
Vinculin, VASP, and profilin are coordinately regulated during actin remodeling in epithelial cells, which requires de novo protein synthesis and protein kinase signal transduction pathways
Margaret P Quinlan
Cell Cycle (Georgetown, Tex.)
|
April 18, 2008
Explaining the preponderance of Kras mutations in human cancer: An isoform-specific function in stem cell expansion
Margaret P Quinlan, Jeffrey Settleman
Future Oncology (London, England)
|
February 27, 2009
Isoform-specific ras functions in development and cancer
Margaret P Quinlan, Jeffrey Settleman
AI Zheng = Aizheng = Chinese Journal of Cancer
|
July 9, 2008
[A Kras-specific function in cancer initiation]
Margaret P Quinlan, Jeffrey Settleman
Seminars in Cell & Developmental Biology
|
March 18, 2008
Transitions between epithelial and mesenchymal states in development and disease
Buzz Baum, Jeffrey Settleman, Margaret P Quinlan
Virology
|
August 31, 2002
Differential effects of DNA tumor virus genes on the expression profiles, differentiation, and morphogenetic reprogramming potential of epithelial cells
Kyoko Takeuchi, Kazuhiro Sakurada, Hitoshi Endou, et al.
Molecular and Cellular Biology
|
February 13, 2008
Activated Kras, but not Hras or Nras, may initiate tumors of endodermal origin via stem cell expansion
Margaret P Quinlan, Steven E Quatela, Mark R Philips, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2008
Reduced Erlotinib sensitivity of epidermal growth factor receptor-mutant non-small cell lung cancer following cisplatin exposure: a cell culture model of second-line erlotinib treatment
Tan Min Chin, Margaret P Quinlan, Anurag Singh, et al.
Cell
|
April 8, 2010
A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations
Sreenath V Sharma, Diana Y Lee, Bihua Li, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Cancer Biology & Therapy
|
January 17, 2004
Suppression of epithelial cell transformation and induction of actin dependent differentiation by dominant negative Rac1, but not Ras, Rho or Cdc42
Margaret P Quinlan
Journal of Cellular Physiology
|
June 3, 2004
Vinculin, VASP, and profilin are coordinately regulated during actin remodeling in epithelial cells, which requires de novo protein synthesis and protein kinase signal transduction pathways
Margaret P Quinlan
Cell Cycle (Georgetown, Tex.)
|
April 18, 2008
Explaining the preponderance of Kras mutations in human cancer: An isoform-specific function in stem cell expansion
Margaret P Quinlan, Jeffrey Settleman
Future Oncology (London, England)
|
February 27, 2009
Isoform-specific ras functions in development and cancer
Margaret P Quinlan, Jeffrey Settleman
AI Zheng = Aizheng = Chinese Journal of Cancer
|
July 9, 2008
[A Kras-specific function in cancer initiation]
Margaret P Quinlan, Jeffrey Settleman
Seminars in Cell & Developmental Biology
|
March 18, 2008
Transitions between epithelial and mesenchymal states in development and disease
Buzz Baum, Jeffrey Settleman, Margaret P Quinlan
Virology
|
August 31, 2002
Differential effects of DNA tumor virus genes on the expression profiles, differentiation, and morphogenetic reprogramming potential of epithelial cells
Kyoko Takeuchi, Kazuhiro Sakurada, Hitoshi Endou, et al.
Molecular and Cellular Biology
|
February 13, 2008
Activated Kras, but not Hras or Nras, may initiate tumors of endodermal origin via stem cell expansion
Margaret P Quinlan, Steven E Quatela, Mark R Philips, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2008
Reduced Erlotinib sensitivity of epidermal growth factor receptor-mutant non-small cell lung cancer following cisplatin exposure: a cell culture model of second-line erlotinib treatment
Tan Min Chin, Margaret P Quinlan, Anurag Singh, et al.
Cell
|
April 8, 2010
A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations
Sreenath V Sharma, Diana Y Lee, Bihua Li, et al.
Page
of 2